Skip to main content

FDA Approvals

FDA Approvals
Selinexor a Promising Oral Option in Triple-Class Refractory Multiple Myeloma
Wayne Kuznar
Wayne Kuznar
Read More
FDA Approvals, In the News
FDA Approves Pembrolizumab for Treatment of Advanced Melanoma
Read More
FDA Approvals, In the News
FDA Approves Split-Dosing Regimen for Daratumumab in Patients with Multiple Myeloma
Read More
FDA Approvals, In the News
February 1, 2019 - FDA Approvals, News & Updates
Read More
FDA Approvals, In the News
Government Shutdown Impacts FDA Drug Approvals
Read More
FDA Approvals
Ivosidenib a New Standard of Care for Relapsed or Refractory AML with IDH1 Mutation
Phoebe Starr
Read More
FDA Approvals
LOXO-292 Highly Effective in RET-Positive Cancers
Chase Doyle
Read More
FDA Approvals
FDA Approvals, News & Updates - August 2018
Read More
FDA Approvals
Oncology Drugs Approved by the FDA in Early 2018
Read More
FDA Approvals
A “Gold Standard” for Population Health? Revisiting the FDA’s Relationship with the Hippocratic Oath
Gillian Woollett, MA, DPhil , Bruce S. Pyenson, FSA, MAAA
Read More
Page 26 of 53
Results 251 - 260 of 524